Perrigo gets go-ahead for new infant products
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Perrigo's first new infant formula products since the Allegan, Mich., firm acquired PBM Holdings in March. Perrigo's partner, Quebec-based Kerry Proteins and Nutritionals, will manufacture the products, the private labeler said Aug. 23. The approved products include concentrate and ready-to-use milk-based infant formula with arachidonic and docosahexaenoic acids. The ready-to-use product also comes in an organic version. "This is the first launch of new products since acquiring our infant nutrition business and we look forward to further new product introductions," said CEO Joseph Papa. Collins Stewart analysts said the approvals allow Perrigo to produce store brands to compete with Abbott's Similac Advance and Mead Johnson's Enfamil Premium (1"The Tan Sheet" March 29, 2010)
You may also be interested in...
Perrigo Grows Into Adjacent Infant Formula Category With PBM Acquisition
Perrigo takes the next step toward becoming a one-stop shop for private-label consumer health products with its $808 million acquisition of infant formula and baby food firm PBM Holdings Inc
P&G's $8M Benzene Settlement Preliminarily Approved By Ohio Federal Court
The Cincinnati, OH-based firm will pay $8m to recompense Unites States residents who purchased aerosol personal-care products potentially contaminated with benzene over a roughly six-year period.
Food For Thought On US FDA Reforms
An independent review of the US FDA’s food regulatory programs could renew a debate over splitting FDA into two agencies. That could be a distraction for the agency in the coming year – but it could also help keep the medical product review groups out of the political hot seat.